5 Patents
- US124602292025Recombinant Arterivirus Replicon Systems and Uses Thereof
Janssen Pharmaceuticals, Inc.
0 cites - US123310762025Alphavirus-based Replicons for Administration of Biotherapeutics
Janssen Pharmaceuticals, Inc.
0 cites - 0 cites
- US118264162023Induce and Enhance Immune Responses Using Recombinant Replicon Systems
Janssen Pharmaceuticals, Inc.
0 cites - US115552052023Recombinant Arterivirus Replicon Systems and Uses Thereof
Janssen Pharmaceuticals, Inc.
0 cites